Goldman Sachs Maintains Neutral on Gentex, Lowers Price Target to $31
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Mark Delaney has maintained a Neutral rating on Gentex (NASDAQ:GNTX) but has lowered the price target from $33 to $31.
October 01, 2024 | 5:55 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Goldman Sachs has maintained a Neutral rating on Gentex but reduced the price target from $33 to $31, indicating a slightly less optimistic outlook.
The lowering of the price target by Goldman Sachs suggests a slightly less optimistic view on Gentex's future performance, which could lead to a short-term negative impact on the stock price. The Neutral rating indicates no strong buy or sell recommendation, but the reduced price target may influence investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100